Mismatched transplants for refractory lymphoma?

Lancet

Volumn 353, Issue 9166, 1999, Pages 1725-1726

  Falkenburg, J H Frederik ^a   Kluin Nelemans, Hanneke C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HLA ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGRAFT; AUTOIMMUNE DISEASE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIESIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE TRANSFUSION; LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

EID: 0033594729     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)00402-4     Document Type: Note

References (10)

1. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-50.
2. Collins Jr RH, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-44.
3. Falkenburg JHF, Smit WM, Willemze R. Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunol Rev 1997; 157: 223-30.
4. Smit WM, Rijnbeek M, van Bergen CAM, Fibbe WE, Willemze R, Falkenburg JHF. Cytotoxic T cells recognizing leukemic CD34 positive progenitor cells mediate the anti leukemic reactivity of donor lymphocyte transfusion for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci USA 1998; 95: 10152-57.
5. Bachar-Lustig E, Rachamim N, Hong-Wei L, Lan F, Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995; 1: 1268-73.
6. Slavin S, Nagler A, Naparastek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-63.
7. Khouri IF, Keating M, Körbling M, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817-24.
8. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 1985; 102: 596-602.
9. Fisher RI, Silver BA, Vanhaelen CP, Jaffe ES, Cossman J. Objective regressions of T-and B-cell lymphomas in patients following treatment with anti-thymocyte globulin. Cancer Res 1982; 42: 2465-69.
10. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997; 157: 125-40.